Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the issuance of a new patent in Japan for its ...

Singer Linda Nolan, part of the famed Irish family group The Nolans, died on Jan. 15, 2025, at the age of 65. Nolan, ...

The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in ...

Lung cancer is one of the deadliest forms of cancer, and for many patients, asbestos exposure may be to blame. You may be eligible for compensation if you've been diagnosed with lung cancer caused by ...

Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

However, metformin did not protect Black patients against squamous cell carcinoma specifically ... protective agent against non-melanoma skin cancer, especially after adjusting for medications ...

in patients with small cell lung cancer (SCLC) or Merkel Cell Carcinoma (MCC). The SANTANA-225 trial is a global, open-label Phase I/II study, that will assess the safety, tolerability ...